Quick Answer
ANI PHARMACEUTICALS INC reported Earnings Per Share Diluted of $3.32 per share for the year ending 2025.
- ANI PHARMACEUTICALS INC showed an increase of +419.2% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from ANI PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), ANI PHARMACEUTICALS INC's Earnings Per Share Diluted has grown by 337.1%.
- Historical annual values: Fiscal year 2025: $3.32 per share | Fiscal year 2024: $1.04 (loss) per share | Fiscal year 2023: $0.85 per share | Fiscal year 2022: $3.05 (loss) per share | Fiscal year 2021: $3.40 (loss) per share | Fiscal year 2020: $1.88 (loss) per share | Fiscal year 2019: $0.50 per share | Fiscal year 2018: $1.30 per share | Fiscal year 2017: $0.09 (loss) per share | Fiscal year 2016: $0.34 per share | Fiscal year 2015: $1.32 per share | Fiscal year 2014: $2.59 per share | Fiscal year 2013: $0.92 (loss) per share | Fiscal year 2012: $1.27 (loss) per share | Fiscal year 2011: $3.15 (loss) per share | Fiscal year 2010: $4.21 (loss) per share | Fiscal year 2009: $1.40 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: